Absci (ABSI) Stock Forecast, Price Target & Predictions
ABSI Stock Forecast
Absci stock forecast is as follows: an average price target of $6.00 (represents a 50.00% upside from ABSI’s last price of $4.00) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ABSI Price Target
The average price target for Absci (ABSI) is $6.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 50.00% upside from ABSI's last price of $4.00.
ABSI Analyst Ratings
According to 4 Wall Street analysts, Absci's rating consensus is 'Buy'. The analyst rating breakdown for ABSI stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Absci Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 21, 2024 | Daniel Arias | Stifel Nicolaus | $6.00 | $5.28 | 13.64% | 50.00% |
The latest Absci stock forecast, released on Mar 21, 2024 by Daniel Arias from Stifel Nicolaus, set a price target of $6.00, which represents a 13.64% increase from the stock price at the time of the forecast ($5.28), and a 50.00% increase from ABSI last price ($4.00).
Absci Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $4.00 | $4.00 | $4.00 |
| Upside/Downside | -100.00% | -100.00% | 50.00% |
In the current month, the average price target of Absci stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Absci's last price of $4.00. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 01, 2024 | Guggenheim | - | Buy | Initialise |
| Aug 15, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 03, 2024 | Morgan Stanley | - | Overweight | Initialise |
| Jun 28, 2024 | Cowen & Co. | Buy | Buy | Hold |
| May 15, 2024 | Truist Financial | Sector Outperform | Sector Outperform | Hold |
| Mar 22, 2024 | Scotiabank | Sector Outperform | Sector Outperform | Hold |
| Jan 08, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 12, 2022 | Cowen & Co. | - | Outperform | Upgrade |
Absci's last stock rating was published by Guggenheim on Oct 01, 2024. The company Initialise its ABSI rating from "null" to "Buy".
Absci Financial Forecast
Absci Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $744.00K | $3.37M | $1.27M | $1.56M | $2.37M | $1.00M | $819.00K | $1.45M | $1.54M | $728.00K |
| Avg Forecast | $8.50M | $12.95M | $6.65M | $6.55M | $1.82M | $1.75M | $1.91M | $2.10M | $900.00K | $3.00M | $2.44M | $2.25M | $4.73M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| High Forecast | $8.50M | $12.95M | $6.65M | $6.55M | $1.82M | $2.84M | $1.91M | $2.10M | $1.18M | $3.00M | $2.44M | $2.25M | $4.73M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| Low Forecast | $8.50M | $12.95M | $6.65M | $6.55M | $1.82M | $990.49K | $1.91M | $2.10M | $154.28K | $3.00M | $2.44M | $2.25M | $4.73M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.25% | 1.38% | 0.56% | 0.33% | 1.26% | 0.62% | 0.46% | 0.86% | 0.77% | 0.42% |
Absci's average Quarter revenue forecast for Dec 23 based on 4 analysts is $900.00K, with a low forecast of $154.28K, and a high forecast of $1.18M. ABSI's average Quarter revenue forecast represents a 20.97% increase compared to the company's last Quarter revenue of $744.00K (Sep 23).
Absci EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-18.74M | $-16.57M | $-19.52M | $-16.10M | $-23.89M | $-25.60M | $-25.77M | $-30.17M | $-22.35M | $-43.60M |
| Avg Forecast | $-8.50M | $-12.95M | $-6.65M | $-6.55M | $-1.82M | $-1.75M | $-1.91M | $-2.10M | $-900.00K | $-3.00M | $-2.44M | $-2.25M | $-4.73M | $-1.87M | $-1.62M | $-22.22M | $-1.69M | $-14.90M | $-1.75M |
| High Forecast | $-8.50M | $-12.95M | $-6.65M | $-6.55M | $-1.82M | $-990.49K | $-1.91M | $-2.10M | $-154.28K | $-3.00M | $-2.44M | $-2.25M | $-4.73M | $-1.87M | $-1.62M | $-17.77M | $-1.69M | $-11.92M | $-1.75M |
| Low Forecast | $-8.50M | $-12.95M | $-6.65M | $-6.55M | $-1.82M | $-2.84M | $-1.91M | $-2.10M | $-1.18M | $-3.00M | $-2.44M | $-2.25M | $-4.73M | $-1.87M | $-1.62M | $-26.66M | $-1.69M | $-17.88M | $-1.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | 6.25% | 6.80% | 8.69% | 3.40% | 12.75% | 15.79% | 1.16% | 17.82% | 1.50% | 24.91% |
undefined analysts predict ABSI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Absci's previous annual EBITDA (undefined) of $NaN.
Absci Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | $-21.99M | $-41.67M | $-23.36M | $-19.47M | $-27.26M | $-28.68M | $-29.49M | $-25.17M | $-23.63M | $-41.20M |
| Avg Forecast | $-11.86M | $-8.47M | $-12.42M | $-13.55M | $-21.47M | $-21.92M | $-20.49M | $-23.90M | $-24.00M | $-25.97M | $-26.88M | $-26.20M | $-28.41M | $-31.96M | $-35.25M | $-25.43M | $-27.89M | $-15.76M | $-19.36M |
| High Forecast | $-11.86M | $-8.47M | $-12.42M | $-13.55M | $-21.47M | $-20.77M | $-20.49M | $-23.90M | $-21.91M | $-25.97M | $-26.88M | $-26.20M | $-28.41M | $-31.96M | $-35.25M | $-20.34M | $-27.89M | $-12.60M | $-19.36M |
| Low Forecast | $-11.86M | $-8.47M | $-12.42M | $-13.55M | $-21.47M | $-23.07M | $-20.49M | $-23.90M | $-28.17M | $-25.97M | $-26.88M | $-26.20M | $-28.41M | $-31.96M | $-35.25M | $-30.51M | $-27.89M | $-18.91M | $-19.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.85% | 1.55% | 0.89% | 0.69% | 0.85% | 0.81% | 1.16% | 0.90% | 1.50% | 2.13% |
Absci's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ABSI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Absci SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | $9.51M | $9.41M | $9.59M | $7.75M | $11.41M | $10.51M | $10.89M | $9.18M | $9.73M | $5.18M |
| Avg Forecast | $38.34M | $58.41M | $29.99M | $29.54M | $8.21M | $7.91M | $8.60M | $9.47M | $4.06M | $13.53M | $10.99M | $10.13M | $21.33M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| High Forecast | $38.34M | $58.41M | $29.99M | $29.54M | $8.21M | $12.82M | $8.60M | $9.47M | $5.34M | $13.53M | $10.99M | $10.13M | $21.33M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| Low Forecast | $38.34M | $58.41M | $29.99M | $29.54M | $8.21M | $4.47M | $8.60M | $9.47M | $695.89K | $13.53M | $10.99M | $10.13M | $21.33M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.70% | 0.86% | 0.95% | 0.36% | 1.35% | 1.44% | 1.35% | 1.20% | 1.08% | 0.66% |
Absci's average Quarter SG&A projection for Dec 23 is $4.06M, based on 4 Wall Street analysts, with a range of $695.89K to $5.34M. The forecast indicates a -57.29% fall compared to ABSI last annual SG&A of $9.51M (Sep 23).
Absci EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.24 | $-0.45 | $-0.26 | $-0.21 | $-0.30 | $-0.32 | $-0.33 | $-0.28 | $-0.33 | $-0.47 |
| Avg Forecast | $-0.10 | $-0.07 | $-0.11 | $-0.12 | $-0.19 | $-0.19 | $-0.18 | $-0.21 | $-0.21 | $-0.23 | $-0.24 | $-0.23 | $-0.25 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| High Forecast | $-0.10 | $-0.07 | $-0.11 | $-0.12 | $-0.19 | $-0.18 | $-0.18 | $-0.21 | $-0.19 | $-0.23 | $-0.24 | $-0.23 | $-0.25 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| Low Forecast | $-0.10 | $-0.07 | $-0.11 | $-0.12 | $-0.19 | $-0.20 | $-0.18 | $-0.21 | $-0.25 | $-0.23 | $-0.24 | $-0.23 | $-0.25 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 1.89% | 1.12% | 0.83% | 1.06% | 1.03% | 1.14% | 1.13% | 1.63% | 2.73% |
According to undefined Wall Street analysts, Absci's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ABSI previous annual EPS of $NaN (undefined).
Absci Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals | $0.63 | $70.00 | 11011.11% | Buy |
| ELEV | Elevation Oncology | $0.52 | $9.00 | 1630.77% | Buy |
| XFOR | X4 Pharmaceuticals | $0.53 | $3.67 | 592.45% | Buy |
| INZY | Inozyme Pharma | $4.42 | $14.67 | 231.90% | Buy |
| RLAY | Relay Therapeutics | $5.85 | $19.40 | 231.62% | Buy |
| SANA | Sana Bio | $3.76 | $12.00 | 219.15% | Buy |
| DAWN | Day One Biopharmaceuticals | $14.81 | $38.80 | 161.99% | Buy |
| ABOS | Acumen Pharmaceuticals | $2.95 | $7.00 | 137.29% | Buy |
| AFMD | Affimed | $3.27 | $7.50 | 129.36% | Buy |
| DTIL | Precision BioSciences | $8.29 | $15.50 | 86.97% | Buy |
| ABSI | Absci | $4.00 | $6.00 | 50.00% | Buy |
| RXRX | Recursion Pharmaceuticals | $6.64 | $9.67 | 45.63% | Hold |
| CRBU | Caribou Biosciences | $2.34 | $3.00 | 28.21% | Buy |
| GRPH | LENZ Therapeutics | $3.18 | $4.00 | 25.79% | Hold |
| ZURA | Zura Bio | $4.37 | $5.00 | 14.42% | Buy |
| VECT | VectivBio | $16.87 | $18.00 | 6.70% | Buy |
| EXAI | Exscientia | $5.01 | $5.00 | -0.20% | Hold |
ABSI Forecast FAQ
Is Absci a good buy?
Yes, according to 4 Wall Street analysts, Absci (ABSI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of ABSI's total ratings.
What is ABSI's price target?
Absci (ABSI) average price target is $6 with a range of $6 to $6, implying a 50.00% from its last price of $4. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Absci stock go up soon?
According to Wall Street analysts' prediction for ABSI stock, the company can go up by 50.00% (from the last price of $4 to the average price target of $6), up by 50.00% based on the highest stock price target, and up by 50.00% based on the lowest stock price target.
Can Absci stock reach $6?
ABSI's average twelve months analyst stock price target of $6 does not support the claim that Absci can reach $6 in the near future.
What are Absci's analysts' financial forecasts?
Absci's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $7.58M (high $8.67M, low $6.82M), average EBITDA is $-7.58M (high $-6.818M, low $-8.67M), average net income is $-87.78M (high $-86.626M, low $-88.934M), average SG&A $34.19M (high $39.11M, low $30.75M), and average EPS is $-0.777 (high $-0.767, low $-0.787). ABSI's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $34.65M (high $34.65M, low $34.65M), average EBITDA is $-34.65M (high $-34.65M, low $-34.65M), average net income is $-46.303M (high $-46.303M, low $-46.303M), average SG&A $156.29M (high $156.29M, low $156.29M), and average EPS is $-0.41 (high $-0.41, low $-0.41).
Did the ABSI's actual financial results beat the analysts' financial forecasts?
Based on Absci's last annual report (Dec 2022), the company's revenue was $5.75M, which missed the average analysts forecast of $10.02M by -42.62%. Apple's EBITDA was $-91.356M, beating the average prediction of $-30.44M by 200.12%. The company's net income was $-105M, missing the average estimation of $-121M by -13.33%. Apple's SG&A was $40.55M, missing the average forecast of $45.18M by -10.24%. Lastly, the company's EPS was $-1.15, beating the average prediction of $-1.135 by 1.32%. In terms of the last quarterly report (Sep 2023), Absci's revenue was $744K, missing the average analysts' forecast of $3M by -75.20%. The company's EBITDA was $-18.744M, beating the average prediction of $-3M by 524.80%. Absci's net income was $-21.994M, missing the average estimation of $-25.975M by -15.33%. The company's SG&A was $9.5M, missing the average forecast of $13.53M by -29.76%. Lastly, the company's EPS was $-0.24, beating the average prediction of $-0.23 by 4.35%